My investor asked about competitor clearance. I spent 3 days on FDA.gov. Here's the shortcut.
The question sounded simple: "Which cleared devices are closest to yours?" It landed the night before a diligence call when the founder needed an answer that would survive follow-up from an investor and an RA/QA reviewer. FDA.gov had the records, but the useful work was turning scattered public entries into a source-backed shortlist, a safety-history scan, and a clean set of questions for RA/QA.
For founders, manufacturers, RA/QA teams, and regulatory consultants. For RA/QA or consultant review.
This is not regulatory, legal, or compliance advice. Competitor clearances are research inputs. They do not determine your FDA classification, submission pathway, predicate status, or substantial equivalence.
The three-day mistake
The first pass was keyword search: device name, competitor name, and a few guessed phrases typed under time pressure because the meeting invite was already on the calendar. That found FDA pages, but it did not explain whether those records were relevant. The second pass was product-code search. That was better, but still incomplete because similar devices can appear under adjacent names, older technology descriptions, or applicant names that do not match the brand.
At 9:40 p.m. the night before an investor diligence call, the founder still could not answer which cleared devices were closest to the product and why.
The first searches produced 30 FDA tabs, three possible product codes, and no defensible shortlist the RA/QA advisor could review in one sitting.
Product codes, K-numbers, indications, and recall records started to overlap, which made a wrong shortcut more dangerous than saying 'we still need to verify this.'
The useful output was not a conclusion. It was a dated review packet that let RA/QA react to sources instead of untangling search history.
The shortcut: map the evidence around the product
A Product ID Map starts with the candidate product description, intended use, and market question. Then it organizes candidate FDA product-code clues, 510(k) records, similar-device notes, public safety-history records, and consultant-prep questions into one source-cited workspace. The founder still does not make the regulatory call. They walk into the investor or consultant meeting with the right public evidence already sorted, instead of trying to defend memory, browser tabs, or a last-minute guess.
Frequently asked questions
Can a founder search FDA competitor clearances without a consultant?
A founder can search public FDA databases for competitor 510(k) clearances, product-code clues, and recall history. The hard part is not access; it is scoping the query, avoiding false confidence, and turning records into source-backed review questions for RA/QA or a qualified consultant.
Does competitor clearance prove my device can use the same pathway?
No. Competitor clearance is context, not a pathway determination. Intended use, technological characteristics, claims, risk controls, software scope, and evidence all matter. FDA classification, predicate suitability, and substantial equivalence remain qualified RA/QA and FDA review questions.
What does a Product ID Map add to competitor research?
A Product ID Map keeps the candidate device at the center, then organizes product-code clues, 510(k) records, similar-device notes, safety-history signals, and consultant-prep questions with source URLs and dates. It is preparation for review, not a decision engine.
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine FDA classification, submission pathway, predicate status, substantial equivalence, compliance, safety, or effectiveness. We prepare a source-backed evidence pack from public FDA sources so qualified RA/QA professionals or regulatory consultants can review and decide.